Early treatment with the 0.19 mg fluocinolone acetonide implant is associated with improved functional and anatomical outcomes in patients with persistent or recurrent diabetic macular edema

Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma

Bernardete Pessoa1,2; Nisa Silva3; Ana Marta1; João Coelho1; Melo Beirão1,2; Angelina Meireles1,2

Mar 9, 2020